Literature DB >> 7790774

Influence of serum on zinc, toxic shock syndrome toxin-1, and lipopolysaccharide-induced production of IFN-gamma and IL-1 beta by human mononuclear cells.

C Driessen1, K Hirv, N Wellinghausen, H Kirchner, L Rink.   

Abstract

Measurement of cytokine secretion in vitro is usually performed in culture medium supplemented with human serum. We compared the secretion of interferon-gamma and interleukin-1 beta as a parameter for lymphocyte and monocyte activation in RPMI 1640 medium supplemented with fetal calf or autologous serum in serum-free medium and protein-free medium. Four different stimulatory mechanisms were tested: phytohemagglutinin, toxic shock syndrome toxin-1 (TSST-1), lipopolysaccharide (LPS), and zinc ions. We found that the optimal stimulatory zinc concentration depended on the total protein content of the medium, whereas the monokine levels were dependent on the concentration of transport proteins such as transferrin. Monokine induction by LPS or TSST-1 were each influenced by the protein and serum composition in a specific manner. Our results show that the differing mechanisms of cytokine induction are influenced by the medium and serum composition in a diverse but specific manner. Serum- or protein-free medium are especially suitable after superantigen challenge when LPS activity needs to be ruled out or after activation by agents with only a weak stimulatory capacity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790774     DOI: 10.1002/jlb.57.6.904

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  Effects of staphylococcal enterotoxins on human neutrophil functions and apoptosis.

Authors:  D A Moulding; C Walter; C A Hart; S W Edwards
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease.

Authors:  Meika Foster; Samir Samman
Journal:  Nutrients       Date:  2012-07-04       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.